Researchers have developed a new mathematical method for analyzing standard brain scans to predict the onset of Alzheimer’s disease long before symptoms appear. This new tool can track the hidden influence of genetic and cardiovascular risk in healthy adults by assessing how well an individual’s brain matches the structural patterns characteristic of the disease. The study was published in the journal Molecular Psychiatry.
Alzheimer’s disease is the leading cause of cognitive decline in older adults. The gradual changes that lead to this condition begin in the brain decades before the first signs of memory loss or confusion appear. This long preclinical period provides an opportunity for medical interventions aimed at delaying or preventing disease.
Existing methods for detecting these early changes often rely on specialized and expensive techniques. Doctors use radioactive tracers to look for specific proteins in positron emission tomography scans and test spinal fluid and blood. Although these methods are highly accurate, they can be invasive and are not always practical for testing the broader public.
Standard magnetic resonance imaging provides a non-invasive and widely available alternative to brain scanning. However, typical visual signs of the disease on these common scans, such as shrinkage of certain brain folds or enlargement of fluid cavities, are less sensitive. These visible changes usually only appear after memory problems have already begun.
A team of scientists led by Peter Kochunov and L. Elliott Hong of the University of Texas Health Science Center in Houston looked for earlier warning signs. They developed a software measurement called the Regional Vulnerability Index. This is an analysis tool that evaluates the structure of the entire brain at once.
To create the index, researchers first established a universal blueprint for how the disease physically changes the brain over time. They analyzed brain scans of people diagnosed with the disease and found to have a buildup of toxic proteins. They compared these scans with those of healthy adults to map typical local defects throughout the organ.
The resulting index scores the mathematical similarity between an individual’s brain scan and an established disease blueprint. This formula looks at a wide range of structural relationships, rather than just looking at the size of the hippocampus, the brain’s central memory structure. A higher score means that the individual’s brain patterns more closely resemble those expected in dementia.
The researchers wanted to see if this index could capture the lifelong effects of two major risk factors for cognitive decline. They focused on a gene involved in cholesterol transport, known as the apolipoprotein E gene. People who inherit a variant of this gene, known as E4, have a significantly higher risk of developing dementia as they age.
They also examined cardiovascular health, which plays a major role in brain aging. Conditions such as high blood pressure, high cholesterol, and diabetes can slowly damage the blood vessels that supply oxygen and nutrients to the brain. To measure this burden, the team calculated a standardized cardiovascular risk score for each study participant.
The scientists tested their approach on two large groups of neurologically healthy adults. The goal was to see if this index could detect the influence of genetic and cardiovascular risk factors before cognitive problems occur. The first group served as an initial discovery sample for testing mathematical concepts.
This first group included 343 healthy adults from the Amish Connectome Project. This population is very homogeneous both genetically and environmentally. They lead a rural, agricultural lifestyle and have very low rates of alcohol and tobacco use, which helps researchers isolate the effects of risk factors for the specific diseases being studied.
To replicate the study results, the team evaluated a large secondary sample from the UK Biobank dataset. This collection included over 31,000 healthy participants from a variety of urban and suburban settings. Testing the index across widely different living conditions helped demonstrate the robustness of the structural imaging measurements.
In both study groups, healthy adults who carried high-risk gene mutations had significantly higher brain index scores than those who did not. Their brains were already showing subtle structural patterns associated with the disease. This was true even though these participants had no outward neurological symptoms and performed normally on cognitive tests.
When researchers examined the structure of individual brains using traditional methods, they found few structural differences between those with and without high-risk genes. Simple volumetric measurements of memory centers or the outer folds of the brain did not reveal any underlying genetic risk. The mathematical index was found to be highly sensitive to hidden patterns that were missed by basic volume checks.
The study also revealed the interaction between genetic inheritance and cardiovascular health. Among participants carrying high-risk genetic variants, higher cardiovascular risk scores were more strongly correlated with higher brain index scores. Two risk factors appear to combine to move the physical structure of the brain closer to a disease-like state.
In contrast, in participants without genetic risk factors, higher cardiovascular risk scores did not significantly increase brain indices. The researchers pointed out that simply having a genetic mutation does not cause a decline in cardiovascular indicators such as high blood pressure. Rather, poor cardiovascular health appears to have a much more severe impact on the brain in people with localized genetic vulnerabilities.
After proving that the index worked in healthy adults, scientists investigated whether it could predict future cognitive decline in high-risk populations. They used medical records from the Alzheimer’s Disease Neuroimaging Initiative. This longitudinal database tracks the neurological health of older adults over many years.
The researchers focused on about 2,000 older adults with an average age of 74. Approximately half of these participants had mild cognitive impairment at the beginning of the assessment. Mild cognitive impairment refers to a state of slight decline in memory and thinking skills and often acts as a transitional stage between normal aging and full-blown dementia.
The research team followed these participants for up to 10 years. They found that people with mild cognitive impairment who eventually worsened to develop full dementia had significantly higher baseline index scores. This index was successful in distinguishing between patients who experience rapid decline and those who remain stable over many years.
Mathematics scores had the strongest predictive power in the short term. A high baseline index score reliably predicted transition to new dementia within the first 3 years after the initial brain scan. As time periods extended beyond 3 years and further into the future, the accuracy of predicting patient outcomes based on a single baseline scan gradually decreased.
Importantly, participants with mild cognitive impairment who did not progress to dementia had lower index scores. Their brain patterns were statistically similar to those of perfectly healthy older adults. A lower index score suggests a safer neurological course over the next 10 years.
The researchers noted that there are some boundaries to their findings. The three participant groups have very different environmental backgrounds, which introduces statistical noise into the data. The Amish participants lived in rural areas with few harmful practices, while the other groups were representative of modern urban populations with more typical health variations.
Furthermore, the basic anatomical map used to calculate the frailty index was a standard medical tool. These were not explicitly constructed to highlight the precise areas of the brain that shrink during abnormal protein accumulation. By developing specialized structural maps in the future, scientists may be able to further increase the sensitivity of the index to hidden tissue changes.
The research team did not directly compare the index’s accuracy with the current standard screening tool, a positron emission tomography scan. Future studies should directly compare these two screening methods to determine which is more reliable. Alongside advanced blood tests, we also need to test how the new brain index works.
If validated by other labs, this mathematical approach could transform standard medical imaging for older adults. Routine hospital brain scans could be incorporated into software programs to assess hidden neurological risks in patients. Such non-invasive screening can help doctors identify vulnerable patients early and provide preventive treatment before memory loss becomes permanent.
The study, “Biomarkers of Alzheimer’s disease-like brain patterns: understanding risk and predicting disease onset,” was conducted by Peter Kochunov, Si Gao, Lauren E. Salminen, Neda Jahanshad, Talia M. Nir, Paul M. Thompson, Xiaoming Du, Bhim M. Adhikari, Alice Kochunov, Ryan Cassidy, Yizhou Ma, Joshua Chiappelli, Seth Ament, Yezhi Pan, Shuo Chen, Alan R. Shuldiner, Braxton D. Mitchell, L. Jair Soares, L. Elliot Hon.
